MipSalus partners with leading research institutes, medical professionals, and others to develop its breakthrough treatment of Phenylketonuria (PKU) and its home sensor for blood phenylalanine test while refining its proprietary technology platform.

Aarhus University, Denmark 

Aarhus University Hospital, Denmark

Linnaeus University, Sweden

Liverpool University, United Kingdom

The Mater Hospital, Ireland

Rigshospitalet, Denmark

Smerud Medical Research International, Norway

University Hospitals Birmingham, United Kingdom

The Environmental Technology Development and Demonstration Program, Denmark

Innovation Fund Denmark